Mon, Aug 3, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 1.32% in April (3.24% YTD), Healthcare & Biotechnology index best performer with +3.45% (6.10% YTD)

Monday, May 16, 2011
Opalesque Industry Update – Hedge funds gained 1.32% in April according to the Barclay Hedge Fund Index compiled by BarclayHedge. Year-to-date the Index is up 3.24%.

“Higher prices for equities and bonds in April provided an accommodating environment for most hedge fund strategies,” says Sol Waksman, founder and president of BarclayHedge.

“Strength in the bond market despite US dollar weakness and a well bid equity market took many participants by surprise,” says Waksman. “Yet looking at the positive returns of fixed income-based strategies in April, it appears that hedge fund managers were not caught unawares.

All but two of Barclay’s 18 hedge fund indices had gains in April. The Barclay Healthcare & Biotechnology Index was up 3.45%, Technology gained 2.67%, Global Macro was up 1.96%, Emerging Markets gained 1.82%, and the European Equities Index rose 1.78%.

“Hedge funds have made steady progress since September of 2010, as evidenced by eight straight months of gains for the Barclay Hedge Fund Index,” says Waksman.

The Equity Short Bias Index has lost ground for eight months in a row and gave up another 1.94% in April. Equity Short Bias is down 7.66% year-to-date.

The Barclay Fund of Funds Index gained 1.14% in April and is up 1.98% in 2011.

(press release)

Performance tables: Source

BarclayHedge was founded in 1985 and actively tracks more than 6,000 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories and 16 CTA categories.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Other Voices: Same day reporting and the evolving role of fund administrators[more]

    By: Scott Price, Head of Business Development and Client Management for North America, Maitland Ernst & Young’s latest glob

  2. Activist News - Celgene says patent-fighting hedge fund manager wants to short its shares[more]

    From Reuters.com: Celgene Corp, one of the world's largest biotechnology companies, has accused U.S. hedge fund manager Kyle Bass of attempting to profit from his attempts to wipe out several major drug patents through his Coalition for Affordable Drugs. The company asked the U.S. Patent and T

  3. Einhorn's Greenlight Capital hedge fund slumps 6.1 percent in July[more]

    From Reuters/Thefiscaltimes.com: Hedge fund mogul David Einhorn's Greenlight Capital slumped 6.1 percent in July and is now down 9 percent for the year after gold, one of the fund's top holdings, tumbled to five-year lows last week. Greenlight notified clients of its returns late on Friday, ac

  4. Cowen Group, Inc. to acquire Conifer Securities[more]

    Cowen Group, Inc. and Conifer Securities, LLC had announced the signing of a definitive agreement under which Cowen will acquire Conifer Securities, the prime services division of Conifer Financial Services LLC. The transaction, the terms of which have not yet been disclosed, was approved by the boa

  5. Cargill’s Black River Asset to shut down four hedge funds[more]

    Komfie Manalo, Opalesque Asia: Cargill Inc.’s $7.4 billion Black River Asset Management said it was closing four hedge funds with a combined $ 1 billion in assets and start returning investors money over the next several months, various media said. The hedge funds represent 15% of Black River’

 

banner